Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novo Nordisk B | Copenhagen | Healthcare | Pharmaceuticals | DKK 3.19T | 33.8x | 1.3 | DKK 720.90 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.2% Upside | Upgrade to Pro+ | |
H Lundbeck AS | Copenhagen | Healthcare | Pharmaceuticals | DKK 42.95B | 15.9x | 3.6 | DKK 36.30 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.7% Downside | Upgrade to Pro+ | |
H Lundbeck B | Copenhagen | Healthcare | Pharmaceuticals | DKK 42.95B | 15.9x | 3.6 | DKK 44.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.1% Upside | Upgrade to Pro+ | |
ALK-Abello B | Copenhagen | Healthcare | Pharmaceuticals | DKK 35.41B | 46.5x | 0.5 | DKK 160.30 | -5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6% Upside | Upgrade to Pro+ | |
Bavarian Nordic | Copenhagen | Healthcare | Pharmaceuticals | DKK 13.28B | 18.8x | -0.6 | DKK 169 | -17.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Stenocare AS | Copenhagen | Healthcare | Pharmaceuticals | DKK 25.97M | -1.4x | DKK 1.28 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |